Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Metis TechBio CoHKSE:07666 +2.00%6 PS Ratio is 4,080.00 as of Aug. 11, 2026, which is 7% below its 10-year median of 4,373.34. GuruFocus rates HKSE:07666 with a GF Score™ of 6/100. The stock has 1 warning sign investors should review. Among 930 Biotechnology companies, Metis TechBio Co ranks worse than 98.71% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Metis TechBio Co's share price is HK$12.24.
Metis TechBio Co's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was HK$0.00. Hence, Metis TechBio Co's PS Ratio for today is 4,080.00.
The historical rank and industry rank for Metis TechBio Co's PS Ratio or its related term are showing as below:
HKSE:07666'
s PS Ratio Range Over the Past 10 Years
Min: 3353.33 Med: 4373.34 Max: 7233.33
Current: 4080
During the past 4 years, Metis TechBio Co's highest PS Ratio was 7233.33. The lowest was 3353.33. And the median was 4373.34.
HKSE:07666's PS Ratio is ranked worse than 98.71% of 930
companies
in the Biotechnology industry
Industry Median: 9.455
vs HKSE:07666: 4080.00
During the past 12 months, the average Revenue per Share Growth Rate of Metis TechBio Co was 10000.00% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 365.70% per year.
During the past 4 years, Metis TechBio Co's highest 3-Year average Revenue per Share Growth Rate was 365.70% per year. The lowest was 365.70% per year. And the median was 365.70% per year.
Metis TechBio Co (HKSE:07666) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Metis TechBio Co PS Ratio Related Terms
Metis TechBio Co PS Ratio Historical Data
* Premium members only.
The historical data trend for Metis TechBio Co's PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Metis TechBio Co PS Ratio Chart
Metis TechBio Co Annual Data
Trend
Dec22
Dec23
Dec24
Dec25
PS Ratio
0.00
0.00
0.00
0.00
Metis TechBio Co Quarterly Data
Dec22
Dec23
Dec24
Sep25
Dec25
PS Ratio
0.00
0.00
0.00
0.00
0.00
HKSE:07666 vs VRTX, REGN, RVMD: PS Ratio Comparison
For the Biotechnology subindustry, Metis TechBio Co's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Metis TechBio Co PS Ratio vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Metis TechBio Co's PS Ratio distribution charts can be found below:
* The bar in red indicates where Metis TechBio Co's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Metis TechBio Co's Share Price of today is HK$12.24. Metis TechBio Co's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was HK$0.00.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Metis TechBio Co (HKSE:07666) has a PS Ratio of 4,080.00 as of Aug. 11, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Metis TechBio Co and its competitors. This is near median its historical median of 4,373.34. Over the past decade, Metis TechBio Co's PS Ratio has ranged from 3,353.33 to 7,233.33. According to the industry distribution chart, Metis TechBio Co ranks #918 out of 930 companies in the Biotechnology industry, placing it in the top 98.7%.
Is Metis TechBio Co's PS Ratio too high?
Metis TechBio Co's current PS Ratio of 4,080.00 is near median its 10-year median of 4,373.34. Over the past 10 years, this metric has ranged from a low of 3,353.33 to a high of 7,233.33. The Biotechnology industry median PS Ratio is 9.46. Metis TechBio Co's value of 4,080.00 is 43051.8% above this industry median. Based on the distribution chart, Metis TechBio Co ranks #918 out of 930 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Metis TechBio Co has a GF Score™ of 6/100, reflecting its overall financial health beyond just this single metric.
How does Metis TechBio Co's PS Ratio compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Metis TechBio Co ranks #918 out of 930 companies for PS Ratio. This places Metis TechBio Co in the lower half of its industry. The industry median PS Ratio is 9.46. Metis TechBio Co's value of 4,080.00 is 43051.8% above this benchmark. Historically, Metis TechBio Co's own PS Ratio has ranged from 3,353.33 to 7,233.33 over the past decade. While the company's 10-year median is 4,373.34 vs. the industry median of 9.46, Metis TechBio Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Biotechnology company?
The median PS Ratio among Biotechnology companies is 9.46, based on 930 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Metis TechBio Co's current PS Ratio of 4,080.00 is 43051.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Metis TechBio Co and its competitors. For the Biotechnology industry, the median PS Ratio is 9.46 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Metis TechBio Co's current PS Ratio is 4,080.00, which is near median its own 10-year median of 4,373.34. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Metis TechBio Co stock overvalued right now?
Metis TechBio Co (HKSE:07666) has a current PS Ratio of 4,080.00. The current PS Ratio is 4,080.00, which is near median its 10-year median of 4,373.34 and 43051.8% above the Biotechnology industry median of 9.46. Metis TechBio Co's overall GF Score™ is 6/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Metis TechBio Co (HKSE:07666), the current PS Ratio is 4,080.00 as of Aug. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Metis TechBio Co Ltd is an investment holding company. The company and its subsidiaries are principally engaged in AI-empowered nanomaterial innovation for the delivery and application of active agents across all carbon-based life forms. Its technology platform, NanoForge, comprises a set of integrated tools, including a lipid library, AI models, an AI agent (METiS), quantum chemistry and molecular dynamics simulations, and high-throughput screening platforms. The company has developed three solution platforms (AiTEM, AiLNP, and AiRNA) designed to simulate, predict, and interpret nanoscale interactions, enabling the rational design, optimization, and validation of nanomaterials and their associated payloads.
6GF Score
Get the complete analysis for HKSE:07666
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:07666 has been successfully added to your 
